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Avian influenza H9N2 viruses have become panzootic in Eurasia causing respiratory manifestations, great economic
losses and occasionally being transmitted to humans. To evaluate the replication properties and compare the different
virus quantification methods, four Eurasian H9N2 viruses from different geographical origins were propagated in
embryonated chicken egg (ECE) and Madin-Darby canine kidney epithelial cell systems. The ECE-grown and cell
culture-grown viruses were monitored for replication kinetics based on tissue culture infectious dose (TCID50),
Hemagglutination (HA) test and quantitative real time RT-PCR (qRT-PCR). The cellular morphology was analyzed
using immunofluorescence (IF) and cellular ELISA was used to screen the sensitivity of the viruses to amantadine.
The Eurasian wild type-H9N2 virus produced lower titers compared to the three G1-H9N2 viruses at respective
time points. Detectable titers were observed earliest at 16 h post inoculation (hpi), significant morphological changes on
cells were first observed at 32 hpi. Few nucleotide and amino acid substitutions were noticed in the HA, NA and NS gene
sequences but none of them are related to the known conserved region that can alter pathogenesis or virulence
following a single passage in cell culture. All studied H9N2 viruses were sensitive to amantadine. The G1-H9N2 viruses
have higher replication capabilities compared to the European wild bird-H9N2 probably due to their specific genetic
constitutions which is prerequisite for a successful vaccine candidate. Both the ECE and MDCK cell system
allowed efficient replication but the ECE system is considered as the better cultivation system for H9N2 viruses
in order to get maximum amounts of virus within a short time period.Introduction
Avian influenza H9N2 is a low pathogenic avian influenza
virus (LPAIV) which in many countries continues to cause
respiratory diseases, drop in egg production and increase in
mortality among commercial domestic poultry and wild
birds [1-3]. H9N2 viruses become endemic in poultry in
many Eurasian countries particularly in some Asian and
Middle Eastern countries [4]. Molecular genetic analyses of
H9N2 viruses, isolated during the last two decades revealed
that these viruses are highly evolving and a genetically di-
verse population [5]. Furthermore, H9N2 viruses have reas-
sorted with other avian influenza subtypes to generate
multiple novel subtype [6-10]. Additionally, its extensive
species tropism, distribution and ability to donate internal
genes to the highly pathogenic H5 and H7 subtypes [11-14]
evoke particular concerns. The H9 viruses are now also* Correspondence: thomas.vahlenkamp@uni-leipzig.de
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have acquired human virus-like receptor specificity [15]
and are able to be directly transmitted from birds to
humans [16]. Two distinct lineages of H9N2 influenza vi-
ruses, the North American lineage and the Eurasian lineage,
have been defined. The Eurasian H9N2 viruses further
grouped into three sub-lineages: G1, Y280 and Kr-p96323
based on their antigenic and genetic properties [17]. The
G1-H9N2 viruses are widespread and more likely affected
in commercial poultry flocks with moderate clinical signs
whereas, Y280 and Kr-p96323 are apparently circulating in
natural reservoir hosts and more prevalent in their respect-
ive origin areas. Multiple clades of H9N2 viruses such as
G1 and Y280 have been circulating together in China [18].
Additionally, H9N2 co-circulating with other subtypes es-
pecially H5N1 in many countries raised the possibility of
multiple reassorted viruses. Moreover, human infection
with H9N2 viruses was observed and some of them
belonged to the sub-lineage G1 [13,19,20]. Currently theticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
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clades of H9N2 viruses were performed in animal models
[5]. Assessing the fitness of distinct clades of H9N2 showed
that the North American H9N2 virus had the lowest risk
profile while the Eurasian viruses displayed various levels of
fitness across individual assays [5].
Due to the continuous outbreaks of H9N2 in the several
mentioned countries, the development of laboratory tech-
niques for efficient isolation and detection in surveillance
samples continue to be of high priority. Upon receiving a
field sample, virus propagation and isolation are important
for the recovery and production of a viable viral stock for
further laboratory use. The embryonated chicken egg (ECE)
and cell culture systems are generally the basic choice for
influenza virus cultivation. ECEs are considered the gold
standard method of isolation as they are able to support the
growth of a large spectrum of AIVs and their subtypes. The
advantage of the ECE system is the possibility to acquire a
large volume of the viral stock [21] from a single egg, thus,
influenza vaccines have traditionally been prepared in ECEs
[22]. Effective AIV isolation can also be performed in the
cell culture system. The Madin-Darby canine kidney
(MDCK) is the cell line of choice for AIV propagation and
is also recommended by the World Health Organization
[23]. After successful propagation, another important ob-
servation is the virus quantification. Virus quantification
presents a rate-limiting step at many stages of vaccine
development and production, for both egg and cell cul-
ture. Currently, one of the most widely used tools for
the determination of virus concentration is the viral
plaque assay, or variations such as tissue or egg culture
infectious dose (TCID50/EID50). The viral plaque assay
or TCID50/EID50 is a subjective and traditional bio-
logical technique that was originally applied to the
quantification of viruses in the early 1950s [24]. For in-
fluenza viruses, the hemagglutination (HA) assay is also
widely applied. The HA assay is rapid, requires the use
of animal red blood cells, and yields an HA titer value
that is not readily translated into viruses per mL. Another
currently used method for virus quantification includes
quantitative real time PCR (qRT-PCR). Although the qRT-
PCR method does not take into account the infectious
properties of the virus rather can also detect defective virus
particles, it is widely used by many researcher.
In this study, four H9N2 isolates from different sources
(Three G1-H9N2 and one European wild bird-H9N2) were
propagated separately in two recommended effective bio-
logical systems. The virus quantification was carried out
based on TCID50, HA as well as qRT-PCR simultaneously
from all the viruses grown on both systems. The morpho-
logical changes of the embryos and cells at different time
points during propagation were observed. Furthermore, the
genetic evolution of the viruses in a single replication cycle
in cell culture was analyzed as well as all four H9N2 viruseswere checked for amantadine sensitivity. The aim of this
study involved the following objectives; i) Replication effi-
ciency of the H9N2 viruses of different origin, ii) Growth
kinetics of the viruses in two different biological system, iii)
Correlation between different viral quantification methods




Four Eurasian lineage H9N2 viruses: A/chicken/Bangladesh/
VP01/2006 (BVP01), A/turkey/Germany/R869/2012 (GR
869), A/chicken/Saudi Arabia/R61/2002 (SAR61) and A/
chicken/Dubai/F5/2013 (DF5) were used in this study. Gen-
etically, The BVP01 [14], SAR61 and DF5 [25] belong to
G1 lineage, whereas GR869 is an Eurasian wild bird group
(not published). The sequences accession number and de-
tails molecular analysis were available in recently published
article [14,25].
Madin-Darby canine kidney cells (both the parental
MDCK [ATCC® CCL-34™] and its clone MDCK-II
[ATCC® CRL-2936™]) were used for efficient viral propa-
gation of the above mentioned viruses.
Virus propagation in ECE
Specific pathogen free chicken eggs (VALO BioMedia
GmbH, Germany) were used for the ECE propagation
system. Firstly, the H9N2 viruses were inoculated blindly
into the allantoic cavity route of 10-days-old ECE and
incubated at 37 °C. Allantoic fluids (AFs) were harvested
upon the death of the embryo or at 72 h post inocula-
tion (hpi). The presence of virus was confirmed by HA
and subjected to titration. Viral EID50 titers were deter-
mined by injecting 100 μL of 10-fold dilutions of the
virus into the allantoic cavities of 10- days-old eggs. For
each dilution four eggs were used for accurate calcula-
tion of the titer. The 50% end points were calculated ac-
cording to the method of Reed and Muench [26] for
50% egg infectious dose (EID50) and are expressed in
log10 EID50/mL. The virus stock containing the titer of
7.5 log10 EID50/mL was further inoculated into embryo-
nated chicken eggs. Three eggs at each incubation
period of 2, 8, 16, 24, 32, 40, 48, 56 and 72 h were se-
lected and AFs were harvested for the assessment of rep-
lication kinetics.
Virus propagation in cell culture
Confluent monolayers of MDCK and MDCK-II cells
were maintained in cell growth medium (CGM) consist-
ing of Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% fetal calf serum (FCS), 1% Na-
pyruvate and 1% non-essential amino acids (NEAA).
Cells were cultured in T-75 cm2 flasks and incubated at
37 °C in the presence of 5% CO2. For virus inoculation,
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flask as well as in 6-well and 96-well microplates for differ-
ent purposes. The inoculum was prepared by diluting the
virus in growth medium (GM) [CGM without FCS and
supplemented with TPCK-trypsin (2 μg/mL)] at a multipli-
city of infection (moi) of 0.2 and inoculated onto the
monolayer of cells. Infected cells were incubated at 37 °C
for 1 h to allow viral adsorption. Afterwards the inoculum
was removed and GM was added to the monolayer. The
supernatants were harvested at 2, 8, 16, 24, 32, 40, 48, 56
and 64 hpi and stored at −80 °C for virus titration.Assessment of viral replication kinetics
Viral replication kinetics was monitored for infectious
particles by tissue culture infectious dose (TCID50)
assay, HA assay as well as for viral particles by qRT-PCR
targeting the Matrix (M) gene. The influence of H9N2
viruses on cellular morphology was assessed using
immunofluorescence.Hemagglutination assay
The HA assay was performed using 1% washed chicken
red blood cells (RBCs) prepared in PBS according to the
OIE manual [27]. The harvested AFs and cell culture su-
pernatants (CCSs) at selected time points were tested
for hemagglutinating activity. The titers were recorded
to draw the virus replication kinetics and were expressed
by hemagglutination titer unit (HAU). Briefly, 25 μL of
undiluted AF/CCS were added to the first wells of 96-
well V- bottom shaped plates containing 25 μL/well of
PBS. Serial two-fold dilutions were performed followed
by addition of 25 μL PBS to each well. Subsequently,
25 μL of 1% washed chicken RBCs were added to each
well and the plates were incubated for 45 min at room
temperature (RT). The titration was read until the high-
est dilution giving complete agglutination and presented
as log2 HAU/25 μL.TCID50 assay
To determine the infectivity titer, 2 × 104 cells were seeded
in 96-well microplates. The harvested virus from each incu-
bation period of both propagation systems was subjected to
10-fold serial dilutions. Six replicates of 100 μL diluted in-
oculum were transferred to the monolayers of MDCK-II
cells and allowed to adsorb at 37 °C for 1 h. The inoculum
was discarded and 150 μL of GM was added to all wells
containing monolayers. The cells were incubated at 37 °C,
5% CO2 incubator for 32 h. The plates were observed for
cytopathic effect (CPE) and the presence of virus until a
certain dilution was confirmed by immunofluorescence mi-
croscopy. The viral titer was calculated as log10 TCID50/mL
as described by Karber-Spearman [28,29].Immunofluorescence
The 96-well microplates containing MDCK-II cells were
inoculated with the virus and incubated for different
time periods. Following incubation cells were washed 3
times with PBS, fixed with 3.7% formaldehyde for 10 min at
RT and permeabilized with 90% ice cold methanol for
15 min. The plates were washed twice with PBS followed
by addition of 3% bovine serum albumin (BSA) in PBS
as a blocking solution and incubated at RT for 30 min.
Plates were washed again twice and treated with influenza
rabbit anti-nucleoprotein (NP) polyclonal primary antibody
(PA5-32242, Thermo scientific, Germany) at a dilution
of 1:5000. The treated plates were incubated at 37 °C
for 1 h and washed twice with PBS. Secondary antibody
(Alexa Fluor® 488 Goat Anti-Rabbit IgG, Life technologies,
Germany) at 1:1000 dilutions was added and incubated
again for 1 h at 37 °C. Final washing was performed twice
and the plates were left to dry at RT. To investigate the
morphological changes of the cell nucleus, an add-
itional stain, 4, 6-diamidino-2-phenylindole (DAPI),
was used. The plates were observed under fluorescence
microscope (Olympus IX70) and images were captured
for analysis.
Quantitative real time PCR (qRT-PCR)
RNA was isolated from both AFs and CCSs using QIAmp
Viral RNA mini kit (QIAGEN, Hilden, Germany) without
using carrier RNA provided by the kit and reverse tran-
scribed under the standard conditions of RevertAid Reverse
Transcriptase (Thermo Scientific, Germany) using the Uni
12 primer [30]. Diluted cDNA (1:10) was used for the PCR
reaction. A unique primer pair was designed to amplify the
target sequence of the M gene of AIV type A generating a
product of 150 bp (primer sequences are available on
request). The qRT-PCR reactions were carried out ac-
cording to the manufacturer’s instructions using the
Rotor-Gene SYBR Green PCR master mix (QIAGEN,
Hilden, Germany). A pJET 1.2 BVP/ H9N2-M plasmid
was used as a positive control to develop a standard
curve. The genome copy number was calculated based
on the standard curve and expressed as log10 genome
copies/reaction.
Adaptive mutations (HA, NA and NS genes)
To determine the viral adaptive mutations in cell cul-
ture, the hemagglutinin (HA), neuraminidase (NA),
non-structural (NS) and polymerase basic (PB1 & PB2)
genes were sequenced and analyzed after a single pas-
sage. Full length standard RT-PCR was performed and
the PCR products were purified using GeneJET Gel Ex-
traction Kit (Thermo Scientific, City, Germany). The
purified products were subjected to direct nucleotide
sequencing using Rhodamin Dye-Terminator Cycle Se-
quencing Ready Reaction Kit (Big Dye ® Terminator
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ABIPRISM™ 310 genetic Analyser (Applied Biosystems).
The sequence data were edited aligned and analyzed
using three software packages (DNASTER, BioEdit and
MEGA).
Screening of amantadine sensitivity
The sensitivity of the studied H9N2 viruses to amantadine
was assayed in MDCK-II cells according to previously de-
scribed method with modifications [31]. Briefly, 104 TCID50
of the studied H9N2 influenza viruses were tested against
concentrations of 0, 2.5 and 7.5 μg/mL amantadine (Sigma
Aldrich, Steinheim, Germany) in 96 well microtiter plates
by checkerboard titration. The MDCK-II monolayer was
washed and pre-incubated with each drug concentration in
GM for 30 min. In a parallel plate, each titer of the virus
isolate was incubated with the two different drug concen-
trations in GM for 1 h at RT. The drug-containing medium
in the pre-incubated cell culture plate was replaced by drug
treated virus solution from a parallel plate and further incu-
bated for 1 h at 37 °C. Plates were washed and GM contain-
ing the desired concentration of the drug was added. Plates
were incubated at 37 °C for 24 h. Following the removal of
medium, plates were washed with PBS and fixed with 90%
methanol overnight at −20 °C. Subsequently, endogenous
peroxidase activity was blocked by incubation with 3% (v/v)
H2O2 for 1 h followed by blocking in PBS containing 0.05%
Tween-20 and 3% bovine serum albumin. Primary NP anti-
body was added and incubated at RT for 1 h. After washing
with PBS containing 0.05% Tween-20, IgG HRP anti-rabbit
antibody (Thermo scientific, Germany) at 1:1000 dilutions
was added and the plates were incubated 1 h at RT. Freshly
prepared substrate (Dako, Denmark) was added and incu-
bated for 20 min at RT in the dark. Stop solution (H2SO4,
2.5 M) was added and the absorbance OD of the wells was
read at 450/650 nm. The mean OD of the infected cultures
without drug was equal to the total amount of NP protein
(100%). Cultures infected with amantadine-sensitive virus
should produce less than 50% of the total NP protein.
Results
Comparison of hemagglutination (HA) titer
The HA titer was calculated both from the harvested
AFs and CCSs of ECE- grown and cell culture-grown vi-
ruses, respectively. All tested H9N2 viruses did not show
any differences in titers in MDCK and MDCK-II cells,
thus only a diagram representative for MDCK-II is
shown (Figure 1B). Most viruses started yielding HAU
earliest at 16 hpi and reached maximum yield within 32
to 48 hpi which continued until 64 to 72 hpi (Figure 1).
In the ECE system the currently circulating G1 lineage
viruses BVP01, DF5 and SAR61 showed higher yields
than the European wild type GR869. The highest titers
reached by BVP01, DF5, SAR61 and GR869 9log2 (512),9log2 (512), 8 log2 (256) and 5 log2 (32), respectively
(Figure 1A).
On the other hand, in cell culture propagation system
the highest titers recorded by BVP01, DF5, SAR61 and
GR869 were 7log2 (128), 7log2 (128), 5log2 (32) and 3log2
(8), respectively (Figure 1B). The ECE-grown viruses pro-
duced two-fold higher virus yield than the cell culture-
grown viruses.
Replication kinetics based on TCID50
TCID50 count was performed in MDCK-II cells to quan-
tify the virus infectivity and to compare kinetics among
the H9N2 viruses grown in the both systems. The ECE-
and cell culture-grown H9N2 viruses showed detectable
titers at 16 hpi and reached maximum titers at 32 hpi
(Figure 2). The infectivity titers of all ECE-grown H9N2
viruses varied between 3.5 log10 TCID50/mL to 7.8 log10
TCID50/mL. The ECE-grown BVP01 and DF5 viruses
reached maximum yields (~8 log10 TCID50/mL) followed
by SAR61 (~7 log10 TCID50/mL) and GR869 (~5 log10
TCID50/mL) (Figure 2A).
The infectivity titers of cell culture-grown H9N2 strains
varied between 2.3 log10 TCID50/mL to 4.9 log10 TCID50/
mL. Furthermore, the cell culture-grown BVP01, SAR61
and DF5 viruses reached maximum yields (>4 log10 TCID50/
mL) in contrast to GR869 (2.8 log10 TCID50/mL) (Figure 2B).
Thus, the BVP01, SAR61 and DF5 viruses grown in both
the biological systems achieved maximum titers compared
to the GR869. Furthermore, all ECE-grown viruses showed
higher virus yields than the cell culture-grown viruses.
Comparison of viral genome copy number
ECE and MDCK-II systems were capable of supporting
efficient viral replication and did not measured signifi-
cant differences in genome copy number based on the
M gene (Figure 3). The ECE-grown BVP01 (3 log10 gen-
ome copies/reaction), DF5 (3 log10 genome copies/reac-
tion) and SAR61 (~2 log10 genome copies/reaction)
viruses showed detectable copy number earliest at 2 hpi.
The maximum copy number (~7 log10 genome copies/
reaction) was obtained earliest at 16 hpi for BVP01 and
DF5 H9N2 (Figure 3A) whereas, the maximum copy
number (~5.5 log10 genome copies/ reaction) for SAR61
was detected earliest at 48 hpi. The European wild type
GR869 ECE-grown H9N2 showed detectable copy num-
bers earliest at 8 hpi (1 log10 genome copies/reaction)
and reached the maximum (~5 log10 genome copies/re-
action) earliest at 48 hpi (Figure 3A).
On the other hand, cell culture-grown BVP01, DF5,
SAR61 and GR869 viruses exhibited detectable copy
numbers earliest at 8 hpi. The maximum copy number
of BVP01 and DF5 was >6 log10 genome copies/reaction,
detected at 48 hpi. Whereas, the SAR61 showed max-
imum ~5 log10 genome copies/reaction also at 48 hpi
Figure 1 H9N2 growth curve based on hemagglutination unit titer. Comparison of the hemagglutination unit titer of the four studied H9N2
viruses grown in embryonated chicken eggs (A) and MDCK-II cells (B) at different time points.
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copies/reaction at 56 hpi (Figure 3B).
Morphology and progression of infection
The general morphology and spread of ECE- and cell
culture-grown H9N2 viruses were monitored at the speci-
fied time points. In ECE propagation, most embryos were
alive until the last time point chosen in this experiment.
However, some embryos showed nonspecific mortality
earliest at 32 hpi when infected with the same virus and
dose, which might be due to the adverse viral influence on
the embryos. In the cell culture system, both MDCK and
MDCK-II cell lines showed similar morphology during in-
fection; therefore, only the MDCK-II-derived growth
morphology is shown. Firstly, one selected virus (BVP01)
was confirmed at 32 hpi in MDCK-II cells to check theantibody, selected stains and to adjust the suitable control
(Figure 4). On the growth kinetics, the viruses showed CPE
in inverted microscope observation earliest at 16 hpi, al-
though the viral replication was detected at 8hpi when
tested against nucleoprotein (NP) of AIV in IF stain
(Figure 5). CPE was more extensive at 48 to 64 hpi and
>90% cells have detached by 72 hpi. Additionally, on
TCID50 count, the presence of virus by producing CPE was
confirmed at the 2nd dilution while the virus was actually
present until the 5th dilution as confirmed by IF stain. Thus,
the TCID50 titers were considered not only based on CPE
but also considering the highest dilution where NP protein
was recognized by IF stain. The progression of viral infec-
tion in MDCK-II cells varied in morphology at different
time points (Figure 5). Influenza NP protein was detected
by IF at the studied time points suggestive of a high
Figure 2 H9N2 growth curve based on TCID50 titer. Replication kinetics of the four studied H9N2 viruses grown in embryonated chicken egg
(A) and MDCK-II cells (B) at different selected time points.
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cells. At the early time points of infection the viral NP pro-
tein was mostly detected in the nucleus and later dissemi-
nated to the cytoplasm. Significant damage and loss of
nuclear structure of the cells at later time points was clearly
observed by DAPI stain alone. At 64 hpi, very few cells
remained attached to the culture plates.
Sequence analysis and mutation
The HA, NA, NS, PB1 and PB2 genes play important
roles in host-virus interactions and virulence. Thus, therespective gene sequences of cell culture-grown viruses
were compared to the original sequences of the stock
virus (AF stock passage) used as inoculum. The analysis
of the HA, NA and NS genes revealed 2-6 nucleotide
mutations resulting in 1-2 amino acid substitutions de-
pending on the respective genes (Table 1), whereas the
polymerase genes remain similar as inoculum. Import-
antly, none of these nucleotide or amino acid mutations
was observed in the conserved region, which could have
altered pathogenesis or virulence. No amino acid
changes were observed at the HA cleavage site, Receptor
Figure 3 H9N2 growth curve based on M genome copies. Comparison of the four studied H9N2 virus grown in embryonated chicken egg
(A) and MDCK-II cells (B) based on the measurement of M genome copies at different time points.
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HA protein. All of the viruses possessed their respective
motif in the PDZ domain at the C terminal end of the
NS1 protein as inoculum.
Amantadine sensitivity
The drug sensitivity of all four studied H9N2 viruses was
confirmed using in situ ELISA in MDCK-II cells. All tested
viruses were shown to be sensitive to amantadine. Amanta-
dine (2.5 μg/mL or 7.5 μg/mL) inhibited the growth of all
viruses at titers of 4 log10 TCID50/mL. The presence of NP
at amantadine concentration of 2.5 μg/mL was 45%, 34%,
26%, and 55% for BVP01, DF5, GR869 and SAR61, respect-
ively. At amantadine concentrations of 7.5 μg/mL the pres-
ence of NP was accordingly 28%, 34%, 20% and 45%.Discussion
Efficient isolation and propagation of influenza viruses is
important in epidemiological surveillance, study of host-
pathogen interactions, diagnosis and vaccine production.
Successful and efficient propagation of H9N2 virus on
ECE and cell culture system depends on viral dose or
moi, molecular genetic properties of the virus, receptor
binding properties of the host cell and some other virus-
or host-related factors [32-34]. The main focus of this
study was to evaluate efficient H9N2 virus propagation
in two different biological systems. Thus, four different
geographical sources of H9N2 viruses were propagated
in ECEs as well as MDCK and MDCK-II cell lines. Ana-
lyses of the replication kinetics, correlation between the
virus quantification methods, virus adaptations to cell
Figure 4 Detection of influenza virus H9N2 in infected cells. Confirmation of the presence of influenza BVP01/H9N2 virus at 32 hpi in MDCK-II
cells observed by immunofluorescence assay (magnification 20×) using influenza A anti-NP antibodies. A: Infected cells positive for NP protein;
B: Mock control negative for NP staining; C: Merge between NP and DAPI staining on infected cells and D: Mock control positive for DAPI staining.
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viruses were performed.
The replication of influenza virus in a host cell is a poly-
genic process depending on the host cell endocytic path-
ways for entry and transfer of viral genome as well as
activation of host cell signaling [35,36]. Preferentially, avian
influenza viruses bind to terminal α-2,3 SA linkage, whereasFigure 5 Morphological changes of infected cells. Progression of infect
BVP01/H9N2 virus infection as observed by immunofluorescence assay (ma
positive for NP protein and M: Mock control negative for NP staining.human influenza bind to α−2,6 SA. The allantoic cells of
ECEs contain α−2,3 SA Gal while the amniotic cells of
ECEs and MDCK cells contain both linkages [37]. There-
fore, the allantoic cavities are considered to be the preferen-
tial sites for avian influenza virus. In this study, four H9N2
viruses were propagated and replication kinetics were mea-
sured based on HA titer, TCID50 titer and qRT-PCR forion and viral replication in MDCK-II cell at different time points of
gnification 20×) using influenza A anti-NP antibodies. I: Infected cells
Table 1 Sequence analysis after a single passage of the
viruses in MDCK-II compared with the sequence from the
AF stock inoculum
Viruses HA NA NS
nt aa nt aa nt aa
BVP01 6 G270R 1 no 1 NS1:S27L
T279I NS2: no
GR869 3 no no no 1 NS1: Q142E
NS2: no
SAR61 2 no no no 1 NS1: no
NS2: R77K
DF5 5 no 1 no no NS1: no
NS2:no
nt: Nucleotide, aa: Amino acid, no: No substitutions.
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strains were assessed separately in both systems. The four
H9N2 viruses were found to grow efficiently in ECEs and
cell lines. In the cell culture system, both parenteral MDCK
and cloned MDCK-II cells were used however; both cell
lines have shown the same morphology and pattern of rep-
lication kinetics. Thus, only MDCK-II yields were shown in
this study. The cell culture-grown viruses exhibited 2-3 fold
lower virus titers than the ECE grown virus titers, however,
in genome copy number it was 1-1.5 fold lower than the
ECE grown viruses. Although the qRT-PCR method does
not take into account the infectious properties of the virus
rather can also detect defective virus particles. Among the
four studied viruses, the G1 H9N2 (BVP01, DF5 and
SAR61) isolates achieved maximum virus yields in contrast
to the European wild bird (GR869) isolate based on HA
titer, TCID50 titer as well as on genome copy count.
Generally, all the analyzed strains grew well in both
propagation systems, however, the maximum virus yields
and the earliest time points to achieve highest titers var-
ied with the propagation systems as well as with individ-
ual viruses. The ECE system allowed rapid replication
and yielded maximum titers within 16-32 h, whereas cell
culture supported relatively slow replication and yielded
maximum titers after 48 h. In addition, the choice of dif-
ferent moi on virus replication is an important issue
[34]. The moi of 0.2 used in this study for cell culture,
was found to be relatively high as inoculum to generate







A/chicken/Bangladesh/ VP01/2006 PAKSSR*GLF GTSKS N
A/turkey/Germany/R869/2012 PAASGR*GLF GTSKA N
A/chicken/Saudi Arabia/R61/2002 PARSSR*GLF GTSKS N
A/chicken/Dubai/ F5/2013 HARSSR*GLF GTSKS Ncells were found detached in both the cell lines after 64
hpi. Thus, the ECE-propagated viruses reached relatively
higher virus titers compared to cell culture-propagated
viruses at respective time points. Therefore, the ECE
may be considered the better system for the primary
virus isolation from field samples as well as for the viro-
logical surveillance study. Specific receptor binding
properties of embryos also facilitate better replication of
avian origin influenza virus compared to cell lines [38].
The ECE and cell culture are completely different bio-
logical systems which possess differential host-related
factors involved in efficient viral propagation as well as
in variation of viral replication kinetics.
The G1 lineage H9N2 viruses are adapted to poultry
and produced more severe infections than the other
representative lineage of H9N2. Thus, the genetic back-
ground of all studied H9N2 viruses were also consid-
ered for achievement of different replication kinetics at
both propagation systems. Genetically, the BVP01, DF5
and SAR61 (not published) belonged to the G1 lineage,
while GR869 is an Eurasian wild-type reassortant virus (not
published) isolated from turkey which was not adapted to
domestic poultry flocks. Moreover, the genetic variation at
HA cleavage motif, HA receptor binding site (RBS) and C
terminal domain of NS1 protein (Table 2) of four studied
viruses thought to be involve in achievement of different
replication pattern or in virus particle count from two
propagation systems. The binding property of the virus to
the host cell is determined by two factors, the RBS affinity
of the virus and receptor density on the host cell surface
[39]. The RBS motif of the HA protein of the BVP01 and
DF5 revealed an important Q234L (Glutamine to Leucine)
mutation, like the HK-G1strain. However, the SAR61 and
GR869 viruses contain Q at 234 positions (H3 numbering:
226) which is a typical avian virus signature, and it has been
reported that the presence of this aa results in a preference
for binding to α 2,3-linked sialic acid (avian receptors)
whereas viruses having L234 (H9 numbering) showed a
preference for 2,6-linked sialic acid (human receptors) be-
sides avian receptor and a potential cause of reported hu-
man infections [40].
Due to be the member of a separate clade with different
HA cleavage motif, RBS as well as NS1C-terminal domain
(Table 2) the GR869 virus showed comparatively lower rep-
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GLIGR No KSEV L V A S G
GQQGR No ESEV L V A S G
GQQGR No EPEV L V A S G
GLIGR No GSEV L V A N G
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H9N2 viruses, the BVP01 and the DF5 produced kinetics
were somewhat similar with higher replication profile in
contrast of SAR61 which showed lower kinetics. Epidemio-
logically, BVP01 and DF5 viruses were known to induce
clinical signs and caused mortality in commercial poultry
flocks which gives the back draw to yield highest titers in
all the virus quantification methods taken into account in
this study from both the propagation systems.
Amantadine blocks the ion channel formed by M2
protein and inhibits the early step of replication. Sub-
stitutions of amino acid residue such as L26F, V27A,
A30T, S31N and G34E of the M2 protein are already
known to confer resistance to the amantadine [41,42].
The amino acid residue analysis of M2 protein of all studied
H9N2 viruses except one position in DF5 H9N2 (had
substitution S31N), did not showed any substitutions
on those mentioned residues (Table 2). However, at the
amantadine screening on MDCK-II cells at two differ-
ent concentrations confirmed all the studied H9N2
were sensitive to the amantadine M2 blocker drug. The
nucleotide sequences of HA, NA and NS gene from cell
culture-grown viruses did exhibit some mutations com-
pared to the sequence of the inoculum. However, none
of these substitutions were found to alter molecular de-
terminants of pathogenesis.
In conclusion, the virus replication kinetics based on
HA titer, TCID50 titer and the viral genome copies re-
vealed that the three G1-H9N2 viruses (BVP01, DF5
and SAR61) reached highest kinetic level compared to
the European wild type H9N2 (GR869) virus probably
due to the variable genetic constitutions at their spe-
cific conserved region. The species variation of the
GR869 virus may have also affected the replication pro-
file. The virus quantification methods used in this study
have a correlation among themselves as the ECE-grown
and cell culture-grown viruses achieved similar pattern
of replication kinetics from all the quantification
methods. However, this study revealed that the ECE
propagation system allowed better replication as max-
imum virus yield were more than the cell culture-
grown viruses. Thus, the replication efficiency of the
ECE-grown H9N2 viruses was greater probably due to
the specific binding property between the virus and the
host cell. The different virus quantification methods
varied insignificantly. All the studied viruses were
amantadine sensitive and did not exhibit any significant
mutations that are required for the alteration of patho-
genesis after a single replication cycle. This study adds
more insights in the growth properties of the Eurasian
lineage of avian influenza H9N2 in two traditional ef-
fective propagation systems which further help in figur-
ing out a suitable system for the influenza vaccine
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